Profile for United States of America Patent: 8303944
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for United States of America Patent: 8303944
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
⤷ Sign Up | Jul 24, 2029 | Bristol-myers Squibb | DAKLINZA | daclatasvir dihydrochloride |
⤷ Sign Up | Aug 11, 2027 | Bristol-myers Squibb | DAKLINZA | daclatasvir dihydrochloride |
⤷ Sign Up | Aug 8, 2027 | Bristol-myers Squibb | DAKLINZA | daclatasvir dihydrochloride |
>US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |